Calcium Scoring Improves Clinical Management in Patients With Low Clinical Likelihood of Coronary Artery Disease

When a patient with possible coronary disease has a low clinical likelihood of it, the temptation is to test further “just to be sure.” This large study asked whether adding a calcium score to a clinical likelihood estimate helps decide who actually needs more testing — and who can safely be reassured.

Across nearly 40,000 patients, the calcium score reclassified 39 percent of them. The biggest impact fell exactly where it would be most useful: among patients already estimated to be at low risk, the score reclassified 75 percent, and nearly half of those moved into a very low likelihood category — the group for whom additional cardiac testing offers little and can be skipped.

The practical value is efficiency in both directions: avoiding unnecessary downstream tests in people who don’t need them, while still catching unexpected disease. It is a concrete demonstration of calcium scoring as a gatekeeper that sharpens, rather than multiplies, testing.

We rate the evidence strong. It is a large, real-world cohort, with the caveat that, being retrospective and focused on management decisions rather than long-term outcomes, it shows changed care rather than proven survival benefit.